Proposed diagnostic criteria for the Brugada syndrome: consensus report

AAM Wilde, C Antzelevitch, M Borggrefe, J Brugada… - Circulation, 2002 - Am Heart Assoc
in a superior intercostal space in individuals with high clinical suspicion (aborted sudden
cardiac death victims, family members of patients with Brugada syndrome) may also disclose …

Atrial fibrillation: current knowledge and recommendations for management

S Levy, G Breithardt, RWF Campbell… - European heart …, 1998 - academic.oup.com
Atrial fibrillation, a commonly encountered arrhythmia, has in recent years, been the subject
of increased interest and intensive clinical research. There is also increasing awareness that …

Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: an international task force consensus statement

D Corrado, T Wichter, MS Link, RNW Hauer… - Circulation, 2015 - Am Heart Assoc
442 Circulation August 4, 2015 largely composed of patients referred because of their highrisk
status or severe clinical manifestations requiring specialized therapeutic interventions, …

Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the Study on Omega-3 Fatty Acids and Ventricular …

IA Brouwer, PL Zock, AJ Camm, D Böcker, RNW Hauer… - Jama, 2006 - jamanetwork.com
ContextVery-long-chain n-3 polyunsaturated fatty acids (omega-3 PUFAs) from fish are thought
to reduce risk of sudden death, possibly by reducing susceptibility to cardiac arrhythmia.…

Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the …

PA Van Der Zwaag, IAW Van Rijsingen… - European journal of …, 2012 - Wiley Online Library
Aims To investigate whether phospholamban gene (PLN) mutations underlie patients
diagnosed with either arrhythmogenic right ventricular cardiomyopathy (ARVC) or idiopathic …

Implantable cardioverter defibrillator recipients: quality of life in recipients with and without ICD shock delivery: a prospective study

HCM Kamphuis, JRJ De Leeuw, R Derksen… - Ep …, 2003 - academic.oup.com
Aims The experiences of patients who received shocks from their implantable cardioverter
defibrillator (ICD) and how these events affect their overall adjustment are poorly understood. …

Genetic and molecular basis of cardiac arrhythmias: impact on clinical management parts I and II

SG Priori, J Barhanin, RNW Hauer, W Haverkamp… - Circulation, 1999 - Am Heart Assoc
Genetic approaches have succeeded in defining the molecular basis of an increasing array
of heart diseases, such as hypertrophic cardiomyopathy and the long-QT syndromes, …

Activation delay after premature stimulation in chronically diseased human myocardium relates to the architecture of interstitial fibrosis

T Kawara, R Derksen, JR de Groot, R Coronel… - Circulation, 2001 - Am Heart Assoc
Background— Progressive activation delay starting at long coupling intervals of premature
stimuli has been shown to correlate with sudden cardiac death in patients with hypertrophic …

Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy

JP van Tintelen, MM Entius, ZA Bhuiyan, R Jongbloed… - Circulation, 2006 - Am Heart Assoc
Background— Mutations in the plakophilin-2 gene (PKP2) have been found in patients with
arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVC). Hence, genetic …

LocaLisa: new technique for real-time 3-dimensional localization of regular intracardiac electrodes

FHM Wittkampf, EFD Wever, R Derksen, AAM Wilde… - Circulation, 1999 - Am Heart Assoc
Background—Estimation of the 3-dimensional (3D) position of ablation electrodes from
fluoroscopic images is inadequate if a systematic lesion pattern is required in the treatment of …